U.S. Physical Therapy, Inc. (USPH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1162077,
    "name": "U.S. Physical Therapy, Inc.",
    "stock_name": "U.S. Physical Therapy, Inc.",
    "full_name": "U.S. Physical Therapy, Inc.",
    "name_url": "stocks-analysis/us-physical-therapy-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "76.30",
    "chg": 0.89,
    "chgp": "1.18%",
    "dir": 1,
    "prev_price": "75.41",
    "mcapval": "1,477.12",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "S&P 500",
    "isin": "US90337L1089",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "68.11 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/us-physical-therapy-inc-1162077-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is U.S. Physical Therapy, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-us-physical-therapy-inc-technically-bullish-or-bearish-3673502",
        "imagepath": "",
        "date": "2025-11-05 11:18:15",
        "description": "As of 31 October 2025, the technical trend for U.S. Physical Therapy, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a bullish stance for both weekly and monthly periods. However, the weekly KST is bullish, but the monthly KST is bearish, and Dow Theory shows a mildly bearish trend on the weekly timeframe. The daily moving averages are bullish. \n\nIn terms of performance, the stock has underperformed compared to the S&P 500 across multiple periods, with a YTD return of -1.88% versus 16.30% for the S&P 500, and a 5-year return of -1.71% compared to 109.18% for the index. Overall, the current stance is mildly bullish, but the strength is tempered by mixed signals and underperformance relative to the benchmark...."
      },
      {
        "title": "Is U.S. Physical Therapy, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-us-physical-therapy-inc-technically-bullish-or-bearish-3670704",
        "imagepath": "",
        "date": "2025-11-04 11:29:34",
        "description": "As of 31 October 2025, the technical trend for U.S. Physical Therapy, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance, but the weekly Dow Theory shows a mildly bearish outlook. The Bollinger Bands present a mixed view, with weekly readings at mildly bullish and monthly at mildly bearish. Overall, the indicators suggest a mildly bullish sentiment, though there are some bearish signals in the longer-term metrics.\n\nIn terms of performance, the stock has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -2.01% versus the S&P 500's 16.30%, and a 1-year return of 6.82% compared to 19.89% for the benchmark...."
      },
      {
        "title": "U.S. Physical Therapy, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/us-physical-therapys-valuation-grade-changes-from-fair-to-expensive-amid-stock-fluctuations-3667132",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/USPhysicalThera_valuationdot_3667132.png",
        "date": "2025-11-03 15:59:39",
        "description": "U.S. Physical Therapy, Inc. has recently adjusted its valuation, with its stock price at $86.27. Over the past year, the company has seen a 7.60% return, lagging behind the S&P 500. Key metrics include a P/E ratio of 28 and a dividend yield of 198.40%, reflecting its financial standing in the sector."
      },
      {
        "title": "Is U.S. Physical Therapy, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-us-physical-therapy-inc-technically-bullish-or-bearish-3666283",
        "imagepath": "",
        "date": "2025-11-03 11:28:32",
        "description": "As of 31 October 2025, the technical trend for U.S. Physical Therapy, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance. However, the weekly Dow Theory shows a mildly bearish signal, and the monthly KST is bearish. The Bollinger Bands present a mixed view with a mildly bullish weekly and mildly bearish monthly signal. Overall, the technical stance is mildly bullish, driven primarily by the bullish daily moving averages and weekly MACD.\n\nIn terms of performance, the stock has underperformed the S&P 500 across multiple periods, notably with a year-to-date return of -2.75% compared to the S&P 500's 16.30%, and a 3-year return of -2.85% versus 76.66% for the index...."
      },
      {
        "title": "Is U.S. Physical Therapy, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-us-physical-therapy-inc-technically-bullish-or-bearish-3664398",
        "imagepath": "",
        "date": "2025-11-02 11:15:03",
        "description": "As of 31 October 2025, the technical trend for U.S. Physical Therapy, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance, although the weekly KST is bullish and the monthly KST is bearish. The Bollinger Bands show a mildly bullish trend on the weekly chart but a mildly bearish trend on the monthly chart. The Dow Theory presents a mildly bearish view on the weekly timeframe and a mildly bullish view on the monthly timeframe. The OBV is mildly bullish on both weekly and monthly charts.\n\nIn terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -2.75% compared to the S&P 500's 16.30%, and a one-year return of 7.60% versus 19.89% for the index. Overall, the current technical stance is mildly bullish, but the strength is tempered by..."
      },
      {
        "title": "U.S. Physical Therapy, Inc. Experiences Revision in Its Stock Evaluation Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/us-physical-therapys-valuation-grade-changes-from-fair-to-expensive-amid-price-increase-3649105",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/USPhysicalThera_valuationdot_3649105.png",
        "date": "2025-10-27 16:00:45",
        "description": "U.S. Physical Therapy, Inc. has recently adjusted its valuation, with a P/E ratio of 28 and a price-to-book value of 2.70. The company boasts a high dividend yield of 198.40% and solid profitability metrics, including a ROCE of 10.06% and ROE of 9.58%, reflecting strong operational efficiency."
      },
      {
        "title": "Is U.S. Physical Therapy, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-us-physical-therapy-inc-overvalued-or-undervalued-3646072",
        "imagepath": "",
        "date": "2025-10-26 11:07:31",
        "description": "As of 24 October 2025, the valuation grade for U.S. Physical Therapy, Inc. moved from fair to expensive. The company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 28, a Price to Book Value of 2.70, and an EV to EBITDA of 17.32, which are higher than many peers in the industry. For instance, The Ensign Group, Inc. has a P/E of 32.46, while Option Care Health, Inc. has a more favorable EV to EBITDA of 14.37.\n\nIn terms of recent performance, U.S. Physical Therapy has shown a stock return of 13.73% over the past year, which is lower than the S&P 500's return of 16.90% during the same period. This underperformance, combined with its elevated valuation ratios, reinforces the conclusion that the stock is overvalued...."
      },
      {
        "title": "U.S. Physical Therapy, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/us-physical-therapy-inc-technical-trend-upgrades-from-mildly-bullish-to-bullish-amid-stock-price-increase-3601212",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/USPhysicalThera_technicaldot_3601212.png",
        "date": "2025-10-07 20:25:44",
        "description": "U.S. Physical Therapy, Inc. has recently revised its evaluation amid changing market conditions. The stock is currently priced at $89.53, reflecting a year of notable performance fluctuations. Technical indicators present a mixed outlook, while the company has outperformed the S&P 500 in both weekly and annual returns."
      },
      {
        "title": "U.S. Physical Therapy Experiences Revision in Its Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/us-physical-therapys-valuation-grade-changes-from-fair-to-expensive-amid-price-increase-3595446",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/USPhysicalThera_valuationdot_3595446.png",
        "date": "2025-10-06 16:07:43",
        "description": "U.S. Physical Therapy, Inc. has recently adjusted its valuation, with its stock price at $88.94. The company has experienced volatility over the past year, with a high of $101.19 and a low of $62.77. Key financial metrics indicate a competitive position within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 22,
    "sid": "1162077",
    "stock_news_url": "https://www.marketsmojo.com/news/us-physical-therapy-inc-1162077"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is U.S. Physical Therapy, Inc. technically bullish or bearish?

2025-11-05 11:18:15

As of 31 October 2025, the technical trend for U.S. Physical Therapy, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a bullish stance for both weekly and monthly periods. However, the weekly KST is bullish, but the monthly KST is bearish, and Dow Theory shows a mildly bearish trend on the weekly timeframe. The daily moving averages are bullish. In terms of performance, the stock has underperformed compared to the S&P 500 across multiple periods, with a YTD return of -1.88% versus 16.30% for the S&P 500, and a 5-year return of -1.71% compared to 109.18% for the index. Overall, the current stance is mildly bullish, but the strength is tempered by mixed signals and underperformance relative to the benchmark....

Is U.S. Physical Therapy, Inc. technically bullish or bearish?

2025-11-04 11:29:34

As of 31 October 2025, the technical trend for U.S. Physical Therapy, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance, but the weekly Dow Theory shows a mildly bearish outlook. The Bollinger Bands present a mixed view, with weekly readings at mildly bullish and monthly at mildly bearish. Overall, the indicators suggest a mildly bullish sentiment, though there are some bearish signals in the longer-term metrics. In terms of performance, the stock has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -2.01% versus the S&P 500's 16.30%, and a 1-year return of 6.82% compared to 19.89% for the benchmark....

U.S. Physical Therapy, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics

2025-11-03 15:59:39

U.S. Physical Therapy, Inc. has recently adjusted its valuation, with its stock price at $86.27. Over the past year, the company has seen a 7.60% return, lagging behind the S&P 500. Key metrics include a P/E ratio of 28 and a dividend yield of 198.40%, reflecting its financial standing in the sector.

Is U.S. Physical Therapy, Inc. technically bullish or bearish?

2025-11-03 11:28:32

As of 31 October 2025, the technical trend for U.S. Physical Therapy, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance. However, the weekly Dow Theory shows a mildly bearish signal, and the monthly KST is bearish. The Bollinger Bands present a mixed view with a mildly bullish weekly and mildly bearish monthly signal. Overall, the technical stance is mildly bullish, driven primarily by the bullish daily moving averages and weekly MACD. In terms of performance, the stock has underperformed the S&P 500 across multiple periods, notably with a year-to-date return of -2.75% compared to the S&P 500's 16.30%, and a 3-year return of -2.85% versus 76.66% for the index....

Is U.S. Physical Therapy, Inc. technically bullish or bearish?

2025-11-02 11:15:03

As of 31 October 2025, the technical trend for U.S. Physical Therapy, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance, although the weekly KST is bullish and the monthly KST is bearish. The Bollinger Bands show a mildly bullish trend on the weekly chart but a mildly bearish trend on the monthly chart. The Dow Theory presents a mildly bearish view on the weekly timeframe and a mildly bullish view on the monthly timeframe. The OBV is mildly bullish on both weekly and monthly charts. In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -2.75% compared to the S&P 500's 16.30%, and a one-year return of 7.60% versus 19.89% for the index. Overall, the current technical stance is mildly bullish, but the strength is tempered by...

U.S. Physical Therapy, Inc. Experiences Revision in Its Stock Evaluation Metrics

2025-10-27 16:00:45

U.S. Physical Therapy, Inc. has recently adjusted its valuation, with a P/E ratio of 28 and a price-to-book value of 2.70. The company boasts a high dividend yield of 198.40% and solid profitability metrics, including a ROCE of 10.06% and ROE of 9.58%, reflecting strong operational efficiency.

Is U.S. Physical Therapy, Inc. overvalued or undervalued?

2025-10-26 11:07:31

As of 24 October 2025, the valuation grade for U.S. Physical Therapy, Inc. moved from fair to expensive. The company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 28, a Price to Book Value of 2.70, and an EV to EBITDA of 17.32, which are higher than many peers in the industry. For instance, The Ensign Group, Inc. has a P/E of 32.46, while Option Care Health, Inc. has a more favorable EV to EBITDA of 14.37. In terms of recent performance, U.S. Physical Therapy has shown a stock return of 13.73% over the past year, which is lower than the S&P 500's return of 16.90% during the same period. This underperformance, combined with its elevated valuation ratios, reinforces the conclusion that the stock is overvalued....

U.S. Physical Therapy, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-10-07 20:25:44

U.S. Physical Therapy, Inc. has recently revised its evaluation amid changing market conditions. The stock is currently priced at $89.53, reflecting a year of notable performance fluctuations. Technical indicators present a mixed outlook, while the company has outperformed the S&P 500 in both weekly and annual returns.

U.S. Physical Therapy Experiences Revision in Its Stock Evaluation Amid Market Dynamics

2025-10-06 16:07:43

U.S. Physical Therapy, Inc. has recently adjusted its valuation, with its stock price at $88.94. The company has experienced volatility over the past year, with a high of $101.19 and a low of $62.77. Key financial metrics indicate a competitive position within the Pharmaceuticals & Biotechnology sector.

View All News